1. Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., et al. (2005). ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation, 112(12), e154–e235.
2. Lloyd-Jones, D., Adams, R., Carnethon, M., De Simone, G., Ferguson, T. B., Flegal, K., et al. (2009). Heart Disease and Stroke Statistics—2009 Update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 119, e21–e181.
3. Fast Stats. Deaths and Mortality. Center for Disease Control and Prevention. [ http://www.cdc.gov/nchs/fastats/deaths.htm ]. Downloaded: August 10, 2010.
4. Wang SS, Lublin JS. Pfizer plans to abandon heart-drug development. Wall Street Journal. September 30, 2008.
5. Garber, A. M. (2009). An uncertain future for cardiovascular drug development? New England Journal of Medicine, 360, 1169–1171.